NMTC · NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies announced the planned retirement of CFO Ronald McClurg, effective June 30, 2026, after serving since January 2021. McClurg will remain as Senior Advisor until December 31, 2026, to ensure a smooth transition. The company entered into a Transition and Release Agreement providing continued salary and benefits through the retirement date, along with a general release of claims and customary restrictive covenants. Christopher Volker, currently COO, will succeed McClurg as CFO on July 1, 2026. Volker has extensive medtech experience, including senior leadership at Abbott, Cardiovascular Systems, Inc., and St. Jude Medical, and holds a CFA designation. His base salary will increase to $350,000. The transition is structured to maintain continuity in financial leadership, with Volker's background in corporate finance and investment banking expected to support the company's strategic initiatives.